SCYNEXIS Inc.: SCYNEXIS, Inc. to Participate in Upcoming Investor Conferences
January 31, 2017
SCYNEXIS Inc.: SCYNEXIS, Inc. Reports Second Quarter 2016 Financial Results and Provides Company Update
August 08, 2016
SCYNEXIS Inc.: SCYNEXIS, Inc. Announces Sale of Cyclophilin Inhibitor Assets to Cypralis Limited
July 13, 2016
SCYNEXIS Inc.: SCYNEXIS, Inc. Reports First Quarter 2016 Financial Results and Provides Company Update
May 09, 2016
SCYNEXIS Inc.: SCYNEXIS, Inc. Reports Third Quarter 2015 Financial Results and Provides Company Update
November 13, 2015
SCYNEXIS Inc.: SCYNEXIS Appoints Rajeshwar Motheram as Vice President, Pharmaceutical Development
October 07, 2015
SCYNEXIS Inc.: SCYNEXIS, Inc. Announces Board of Directors Transitions
September 28, 2015
SCYNEXIS Inc.: SCYNEXIS, Inc. Reports Second Quarter 2015 Financial Results
August 19, 2015
SCYNEXIS Inc.: SCYNEXIS, Inc. Announces Changes to Board of Directors
June 10, 2015
SCYNEXIS Inc.: SCYNEXIS, Inc. Reports First Quarter 2015 Financial Results
May 15, 2015
SCYNEXIS Inc.: SCYNEXIS, Inc. Reports Full Year 2014 Financial Results
March 30, 2015
SCYNEXIS Inc.: SCYNEXIS, Inc. Appoints Steven C. Gilman, Ph.D., to Board of Directors
February 27, 2015
SCYNEXIS Inc.: SCYNEXIS, Inc. Announces Appointment of Two Seasoned Industry Professionals to Its Board of Directors
December 03, 2014
SCYNEXIS Inc.: SCYNEXIS, Inc. Reports Third Quarter 2014 Financial Results
November 13, 2014
SCYNEXIS Inc.: SCYNEXIS, Inc. Reports Second Quarter 2014 Financial Results
August 13, 2014
SCYNEXIS Inc.: SCYNEXIS Announces Launch of Initial Public Offering of Common Stock
March 24, 2014
